Recent advances in the management of non-small cell lung cancer [version 1; referees: 2 approved]

• Main Authors: Samira Shojaee, Patrick Nana-Sinkam
• Format: Article
• Language: English
• Published: F1000 Research Ltd 2017-12-01
• Series: F1000Research
• Subjects: Lung Cancer
• Online Access: https://f1000research.com/articles/6-2110/v1

Lung cancer is the number one cause of cancer-related death in both men and women. However, over the last few years, we have witnessed improved outcomes that are largely attributable to early detection, increased efforts in tobacco control, improved surgical approaches, and the development of novel targeted therapies. Currently, there are several novel therapies in clinical practice, including those targeting actionable mutations and more recently immunotherapeutic agents. Immunotherapy represents the most significant step forward in eradicating this deadly disease. Given the ever-changing landscape of lung cancer management, here we present an overview of the most recent advances in the management of non-small cell lung cancer.